Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Operating Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Operating Profit (Excl OI) ₹1,195 Cr₹1,635 Cr₹2,320 Cr₹2,084 Cr₹1,698 Cr

What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?

The latest Operating Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,195 Cr based on Mar2025 Consolidated results.
Year Operating Profit
Mar2025₹1,195 Cr
Mar2024₹1,635 Cr
Mar2023₹2,320 Cr
Mar2022₹2,084 Cr
Mar2021₹1,698 Cr

How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?

Years Operating Profit % Change
Mar2025 ₹1,195 Cr
-26.89
Mar2024 ₹1,635 Cr
-29.53
Mar2023 ₹2,320 Cr
11.32
Mar2022 ₹2,084 Cr
22.75
Mar2021 ₹1,698 Cr -

Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,737.5 Cr -0.3% 7.3% 61.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1% 3.3% 14.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0% 10% 45.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,043.0 Cr -2% -0.6% -6.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.3%

7.3%

61.8%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses